PTAB Denies Chinese Co.'s IPR Targeting Cultured Cell Patent
The Patent Trial and Appeal Board has declined to institute inter partes review of a Ventria Biosciences Inc. patent on cell culture media in a challenge brought by Wuhan Healthgen Biotechnology...To view the full article, register now.
Already a subscriber? Click here to view full article